Kiniksa Pharmaceuticals International (KNSA) EV to CFO (2022 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) EV to CFO stood at 51.09 in Q2 2026, down 9.8% from 56.63 a year earlier but up 22.3% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) EV to CFO (2022 - 2026) Analysis & Trends
On a TTM basis, Kiniksa Pharmaceuticals International's EV to CFO came in at 47.12 as of Jun 30, 2026, down 16.8% year-over-year; for FY2025, it was 42.69, down 58.3% from FY2024.
- Annual EV to CFO has declined for three straight years.
- Across earlier years, EV to CFO came in at 102.39 in FY2024 (-40.0%), 170.52 in FY2023 (-47.8%) and 326.91 in FY2022.
- Quarterly EV to CFO has ranged from 34.28 in Q1 2023 to 326.91 in Q4 2022 over the past five years.
- On a year-over-year basis, EV to CFO has declined for seven consecutive quarters, with an average decline of 42.7% over the last seven quarters.
- Peak year-over-year performance for EV to CFO in the last five years was growth of 237.8% in Q1 2024, against a decline of 82.1% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 41.78 (Q1 2026), 42.69 (Q4 2025) and 53.80 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.09 |
| Mar 31, 2026 | 41.78 |
| Dec 31, 2025 | 42.69 |
| Sep 30, 2025 | 53.80 |
| Jun 30, 2025 | 56.63 |
| Mar 31, 2025 | 67.44 |
| Dec 31, 2024 | 102.39 |
| Sep 30, 2024 | 300.94 |
| Jun 30, 2024 | 80.04 |
| Mar 31, 2024 | 115.82 |
| Dec 31, 2023 | 170.52 |
| Jun 30, 2023 | 42.17 |
| Mar 31, 2023 | 34.28 |
| Dec 31, 2022 | 326.91 |
API Access
Kiniksa Pharmaceuticals International EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();